These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7851868)

  • 1. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
    Skutella T; Stöhr T; Probst JC; Ramalho-Ortigao FJ; Holsboer F; Jirikowski GF
    Horm Metab Res; 1994 Oct; 26(10):460-4. PubMed ID: 7851868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats.
    Skutella T; Montkowski A; Stöhr T; Probst JC; Landgraf R; Holsboer F; Jirikowski GF
    Cell Mol Neurobiol; 1994 Oct; 14(5):579-88. PubMed ID: 7621515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.
    Gutiérrez-Mariscal M; de Gortari P; López-Rubalcava C; Martínez A; Joseph-Bravo P
    Psychoneuroendocrinology; 2008 Feb; 33(2):198-213. PubMed ID: 18079066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat.
    Skutella T; Criswell H; Moy S; Probst JC; Breese GR; Jirikowski GF; Holsboer F
    Neuroreport; 1994 Oct; 5(16):2181-5. PubMed ID: 7865772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH
    Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.
    Liebsch G; Landgraf R; Engelmann M; Lörscher P; Holsboer F
    J Psychiatr Res; 1999; 33(2):153-63. PubMed ID: 10221747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactation in rats.
    Skutella T; Probst JC; Caldwell JD; Pedersen CA; Jirikowski GF
    Exp Clin Endocrinol Diabetes; 1995; 103(3):191-5. PubMed ID: 7584522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.
    Standaert DG; Testa CM; Rudolf GD; Hollingsworth ZR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):342-52. PubMed ID: 8558453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide inhibition of angiotensinogen in the brains of rats and sheep.
    McKinley MJ; Guzzo-Pernell N; Sinnayah P
    Methods; 2000 Nov; 22(3):219-25. PubMed ID: 11071817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo.
    Desjardins JP; Iversen PL
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1608-13. PubMed ID: 8531135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
    Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
    Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential anxiolytic role of c-fos antisense oligonucleotide in social-defeated rats].
    Lu XH; Li LJ; Li CQ; Luo XG
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):535-8. PubMed ID: 12516397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro.
    Jessop DS; Harbuz MS; Snelson CL; Dayan CM; Lightman SL
    J Neuroimmunol; 1997 May; 75(1-2):135-40. PubMed ID: 9143246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
    Gleave M; Tolcher A; Miyake H; Nelson C; Brown B; Beraldi E; Goldie J
    Clin Cancer Res; 1999 Oct; 5(10):2891-8. PubMed ID: 10537358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.